In parallel, CCL2 was found to be expressed at the site of metastatic breast cancer localization in the bones (150) and breast cancer-derived CCL2 has acted through CCR2 to promote osteoclast differentiation and contributed to bone metastasis (151). Here, CCL2 is linked to breast cancer.